It has been recognized for thousands of years that light plays a critical part in the health and well-being of human beings. Over the past 10 years, it has been discovered that wavelengths of light are capable of inducing very specific changes in the biochemistry of the body. This field has now matured into the science of photobiomodulation (PBM).

Our focus at Fos Biomedical is in the research and development of photobiomodulation products to improve peoples health. We have a growing portfolio of products that incorporate this technology into a convenient non-transdermal patch.

We are invested in the research of our products and new product developments to provide proven PBM products in this innovative area.

Effects of the Fos Biomedical devices on Cardio-metabolic Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes: A Randomized, Placebo-controlled, Crossover Trial at the Yale-Griffin Prevention Center.

The effects of the non-transdermal Fos Biomedical devices (which utilizes the concept of photobiomodulation) on cardio-metabolic risk factors and sleep quality in people at risk for type 2 diabetes are unclear. Proposed is a randomized crossover placebo-controlled trial to assess the impact of the Fos Biomedical devices use on cardio-metabolic risk factors and sleep quality, among adults at risk for type 2 diabetes.